Journey Medical Corp
DERMNasdaqHealthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $61.2M | $55.1M | $59.7M | $71.0M | $63.1M | $44.5M |
| Operating income | −$8.2M | −$13.7M | −$2.1M | −$27.5M | −$34.9M | $7.9M |
| Net income | −$11.4M | −$14.7M | −$3.9M | −$29.6M | −$44.0M | $5.3M |
| Total assets | $94.6M | $80.2M | $76.8M | $105.2M | $97.3M | $51.9M |
| Total liabilities | $62.7M | $60.2M | $56.5M | $88.2M | $55.2M | $41.6M |
| Equity | $31.9M | $20.1M | $20.4M | $17.0M | $42.0M | $10.3M |
| EPS (diluted) | $-0.47 | $-0.72 | $-0.21 | $-1.69 | $-4.32 | $0.49 |
| Shares out. | 24.5M | 20.4M | 18.2M | 17.5M | 10.2M | 10.8M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −13.3%
- Net margin
- −18.7%
- Return on equity
- −35.9%
- Return on assets
- −12.1%
- Return on capital (ROCE)
- −14.3%
- Liabilities / assets
- 66.3%
- Debt / equity
- 1.97×
- Book value / share
- $1.30
- Revenue growth (YoY)
- 11.1%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -1.40distress
- Accruals / assets
- 1.1%clean
- Piotroski F-Score
- 4/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 3 warning● 2 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- Revenue is growing year-over-year
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 16, 2023
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Vanguard Capital Management LlcPassive (13G)Apr 30, 2026
- Wasatch Advisors LpPassive (13G)Apr 6, 2026
- Tang Capital Management LlcPassive (13G)May 15, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Alloush RamseyOfficer — Chief Operating Officer | Apr 22, 2026 | Grant | 46,863 | $0.00 |
| Benesch JosephOfficer — CFO | Apr 22, 2026 | Grant | 28,907 | $0.00 |
| Maraoui ClaudeOfficer — President & CEO | Apr 22, 2026 | Grant | 49,277 | $0.00 |
| Maraoui ClaudeOfficer — President & CEO | Aug 25, 2025 | Option exercise | 1.3M | $0.07 |
| Rosenwald Lindsay A MdDirector | Aug 5, 2025 | Grant | 50,000 | $0.00 |
| Smith Justin AdamDirector | Aug 5, 2025 | Grant | 20,000 | $0.00 |
| Toledano Miranda JayneDirector | Aug 5, 2025 | Grant | 20,000 | $0.00 |
| Pearce Michael CooperDirector | Aug 5, 2025 | Grant | 20,000 | $0.00 |
| Herskowitz NeilDirector | Aug 5, 2025 | Grant | 20,000 | $0.00 |
| Toledano Miranda JayneDirector | Jun 25, 2025 | Grant | 7,173 | $0.00 |
| Rosenwald Lindsay A MdDirector | Jun 25, 2025 | Grant | 7,173 | $0.00 |
| Pearce Michael CooperDirector | Jun 25, 2025 | Grant | 7,173 | $0.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 3.5M | 11.4 | -5.6% |
| Apr 30, 2026 | 3.7M | 20.8 | -1.2% |
| Apr 15, 2026 | 3.7M | 18.6 | +7.6% |
| Mar 31, 2026 | 3.5M | 7.3 | +31.3% |
| Mar 13, 2026 | 2.6M | 31.0 | +3.4% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsMay 13, 2026
- Other material eventApr 21, 2026
- Results of operationsMar 25, 2026
- Results of operationsNov 12, 2025
- Entered a material agreement · New financial obligationSep 26, 2025
- Entered a material agreement · Terminated a material agreementAug 28, 2025
- Results of operationsAug 12, 2025
- Other material eventJul 14, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 10-QMay 13, 2026
- 8-KFORM 8-KMay 13, 2026
- DEFA14AApr 30, 2026
- DEF 14AApr 30, 2026
- SCHEDULE 13GApr 30, 2026
- 4OWNERSHIP DOCUMENTApr 24, 2026
- 4OWNERSHIP DOCUMENTApr 24, 2026
- 4OWNERSHIP DOCUMENTApr 24, 2026
- 8-KFORM 8-KApr 21, 2026
- SCHEDULE 13G/AApr 6, 2026
- 10-KMar 26, 2026
- 8-KFORM 8-KMar 25, 2026
- 424B3Jan 23, 2026
- 424B3Jan 23, 2026
- EFFECTJan 21, 2026
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.